Intensity Therapeutics, Inc. (INTS) Misses Q1 EPS by 4c

Intensity Therapeutics, Inc. (NASDAQ: INTS) reported Q1 EPS of ($0.22), $0.04 worse than the analyst estimate of ($0.18).

For earnings history and earnings-related data on Intensity Therapeutics, Inc. (INTS) click here.

You May Also Be Interested In

• TJX stock drops as profit outlook falls short of analyst estimates
• Drill Permit Received for Storm Exploration's Gold Standard Project
• Benchmark Reiterates Buy Rating on Synopsys (SNPS) Amid 'Relatively Bearish' Sentiment Into Earnings